These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 31686830)

  • 1. Mild to moderate chronic kidney disease and cardiovascular events in patients with type 2 diabetes mellitus.
    Lessey G; Stavropoulos K; Papademetriou V
    Vasc Health Risk Manag; 2019; 15():365-373. PubMed ID: 31686830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Prediction for Early CKD in Type 2 Diabetes.
    Dunkler D; Gao P; Lee SF; Heinze G; Clase CM; Tobe S; Teo KK; Gerstein H; Mann JF; Oberbauer R;
    Clin J Am Soc Nephrol; 2015 Aug; 10(8):1371-9. PubMed ID: 26175542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albuminuric and non-albuminuric chronic kidney disease in type 1 diabetes: Association with major vascular outcomes risk and all-cause mortality.
    Garofolo M; Russo E; Miccoli R; Lucchesi D; Giusti L; Sancho-Bornez V; Daniele G; Del Prato S; Penno G
    J Diabetes Complications; 2018 Jun; 32(6):550-557. PubMed ID: 29705091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pravastatin in people with diabetes and chronic kidney disease.
    Tonelli M; Keech A; Shepherd J; Sacks F; Tonkin A; Packard C; Pfeffer M; Simes J; Isles C; Furberg C; West M; Craven T; Curhan G
    J Am Soc Nephrol; 2005 Dec; 16(12):3748-54. PubMed ID: 16251235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of chronic kidney disease in Finnish patients with type 2 diabetes treated in primary care.
    Metsärinne K; Bröijersen A; Kantola I; Niskanen L; Rissanen A; Appelroth T; Pöntynen N; Poussa T; Koivisto V; Virkamäki A;
    Prim Care Diabetes; 2015 Feb; 9(1):31-8. PubMed ID: 25066820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient and disease characteristics of type-2 diabetes patients with or without chronic kidney disease: an analysis of the German DPV and DIVE databases.
    Bramlage P; Lanzinger S; van Mark G; Hess E; Fahrner S; Heyer CHJ; Friebe M; Seufert J; Danne T; Holl RW
    Cardiovasc Diabetol; 2019 Mar; 18(1):33. PubMed ID: 30878037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body mass index has no effect on rate of progression of chronic kidney disease in subjects with type 2 diabetes mellitus.
    Mohsen A; Brown R; Hoefield R; Kalra PA; O'Donoghue D; Middleton R; New D
    J Nephrol; 2012; 25(3):384-93. PubMed ID: 22241634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular and all-cause mortality in patients with type 2 diabetes mellitus in the MADIABETES Cohort Study: Association with chronic kidney disease.
    Salinero-Fort MÁ; San Andrés-Rebollo FJ; de Burgos-Lunar C; Abánades-Herranz JC; Carrillo-de-Santa-Pau E; Chico-Moraleja RM; Jiménez-García R; López-de-Andrés A; Gómez-Campelo P;
    J Diabetes Complications; 2016 Mar; 30(2):227-36. PubMed ID: 26627635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Albuminuria and renal function as predictors of cardiovascular events and mortality in a general population of patients with type 2 diabetes: a nationwide observational study from the Swedish National Diabetes Register.
    Svensson MK; Cederholm J; Eliasson B; Zethelius B; Gudbjörnsdottir S;
    Diab Vasc Dis Res; 2013 Nov; 10(6):520-9. PubMed ID: 24002670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incremental risk of cardiovascular disease and/or chronic kidney disease for future ASCVD and mortality in patients with type 2 diabetes mellitus: ACCORD trial.
    Branch M; German C; Bertoni A; Yeboah J
    J Diabetes Complications; 2019 Jul; 33(7):468-472. PubMed ID: 31088728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The burden of unrecognised chronic kidney disease in patients with type 2 diabetes at a county hospital clinic in Kenya: implications to care and need for screening.
    Otieno FCF; Ogola EN; Kimando MW; Mutai K
    BMC Nephrol; 2020 Feb; 21(1):73. PubMed ID: 32111192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of proteinuria and glomerular filtration rate on Taiwanese patients with diabetes mellitus and advanced chronic kidney disease: a single center experience.
    Chen PM; Wada T; Chiang CK
    Clin Exp Nephrol; 2017 Apr; 21(2):307-315. PubMed ID: 27339442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of chronic kidney disease definition on assessment of its incidence and risk factors in patients with newly diagnosed type 1 and type 2 diabetes in the UK: A cohort study using primary care data from the United Kingdom.
    González-Pérez A; Saéz ME; Vizcaya D; Lind M; García Rodríguez LA
    Prim Care Diabetes; 2020 Aug; 14(4):381-387. PubMed ID: 31791904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes.
    Papademetriou V; Lovato L; Doumas M; Nylen E; Mottl A; Cohen RM; Applegate WB; Puntakee Z; Yale JF; Cushman WC;
    Kidney Int; 2015 Mar; 87(3):649-59. PubMed ID: 25229335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of retinopathy and chronic kidney disease on long-term mortality in type 2 diabetic inpatients with normal urinary albumin or protein: a retrospective cohort study.
    Li YH; Sheu WH; Lee IT
    BMJ Open; 2018 Jul; 8(7):e021655. PubMed ID: 30049696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular disease and its relationship with chronic kidney disease.
    Liu M; Li XC; Lu L; Cao Y; Sun RR; Chen S; Zhang PY
    Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2918-26. PubMed ID: 25339487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor 23 and incident CKD in type 2 diabetes.
    Isakova T; Craven TE; Lee J; Scialla JJ; Xie H; Wahl P; Marcovina SM; Byington RP; Wolf M
    Clin J Am Soc Nephrol; 2015 Jan; 10(1):29-38. PubMed ID: 25343949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-normal serum uric acid predicts the development of chronic kidney disease in patients with type 2 diabetes mellitus and preserved kidney function.
    Kim WJ; Kim SS; Bae MJ; Yi YS; Jeon YK; Kim BH; Song SH; Kim IJ; Kim YK
    J Diabetes Complications; 2014; 28(2):130-4. PubMed ID: 24438886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining the contribution of chronic kidney disease to all-cause mortality in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study.
    Penno G; Solini A; Bonora E; Orsi E; Fondelli C; Zerbini G; Trevisan R; Vedovato M; Cavalot F; Laviola L; Nicolucci A; Pugliese G;
    Acta Diabetol; 2018 Jun; 55(6):603-612. PubMed ID: 29574497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.